A furan ring expansion approach to the synthesis of novel pyridazino-psoralen derivatives

Tetrahedron

Volumn 61, Issue 20, 2005, Pages 4805-4810

  González Gómez, José C ^a   Santana, Lourdes ^a   Uriarte, Eugenio ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Benzofurans; Diels Alder; DNA intercalants; Psoralens; Tetrazines

Indexed keywords

2,3 DIHYDROBENZO[1,2 B:5,4 B']DIFURAN; 2,3,5,6 TETRAHYDROBENZO[1,2 B:5,4 B']DIFURAN; 2,3,5,6 TETRAHYDROBENZO[1,2 B:5,4 B']DIFURAN 8 CARBOXALDEHYDE; 5,9 DIOXOBENZO[1,2 B:5,6 B']DIPYRANBIS[3,4 C]PYRIDAZINE 2,12 DICARBOXYLIC ACID METHYL ESTER; 7 FORMYL 5,9 DIOXOBENZO[1,2 B:5,6 B']DIPYRANBIS[3,4 C]PYRIDAZINE 2,12 DICARBOXYLIC ACID METHYL ESTER; 7 FORMYLPYRIDAZINO[3,4 C]PSORALEN 2 CARBOXYLIC ACID METHYL ESTER; 7 HYDROXYMETHYL 1,4 DIHYDROPYRIDAZINO[3,4 C]PSORALEN 2 CARBOXYLIC ACID METHYL ESTER; 7 [[2 (DIMETHYLAMINO)ETHYL]AMINOMETHYL] 1,4 DIHYDROPYRIDAZINO[3,4 C]PSORALEN 2 CARBOXYLIC ACID METHYL ESTER; 9,10 DIHYDROPYRIDAZINO[3,4 C]PSORALEN 2 CARBOXYLIC ACID METHYL ESTER; BENZO[1,2 B:5,4 B']DIFURAN; BENZO[1,2 B:5,4 B']DIFURAN 8 CARBOXALDEHYDE; FURAN; PSORALEN DERIVATIVE; PYRIDAZINE DERIVATIVE; PYRIDAZINO[3,4 C]PSORALEN 2 CARBOXYLIC ACID METHYL ESTER; RESORCINOL; UNCLASSIFIED DRUG;

AMINATION; ARTICLE; CHEMICAL REACTION KINETICS; DRUG SYNTHESIS; LITHIATION; OXIDATION KINETICS; PRIORITY JOURNAL; REDUCTION KINETICS;

BETULACEAE;

EID: 17844396930     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2005.03.018     Document Type: Article

References (32)

1. For a recent review L. Santana, E. Uriarte, F. Roleira, N. Milhazes, and F. Borges Curr. Med. Chem. 11 2004 3239 3261
2. L. Dalla Via, and S. Marciani-Magno Curr. Med. Chem. 8 2001 1405 1418
3. G. Rodighiero, F. Dall'Acqua, and D. Averbeck F.P. Gasparro Psoralen DNA Photobiology 1988 CRC Boca Raton, FL 34 114
4. L. Dalla Via, O. Gia, S. Marciani-Magno, L. Santana, M. Teijeira, and E. Uriarte J. Med. Chem. 42 1999 4405 4413
5. L. Santana, E. Uriarte, L. Dalla Via, and O. Gia Bioorg. Med. Chem. Lett. 10 2000 135 137
6. G.B. Jones M. Palumbo Advances in DNA-Sequence-Specific Agents Vol. 3 1998 JAI London
7. L. Dalla Via, E. Uriarte, E. Quezada, A. Dolmella, M.G. Ferlin, and O. Gia J. Med. Chem. 46 2003 3800 3810
8. L. Lee, and J.K. Snyder M. Harmata Advances in Cycloadditions Vol. 6 2001 JAI Stamford, CT 119 171
9. D.L. Boger J. Heterocycl. Chem. 35 1998 1001 1011
10. D.L. Boger J. Heterocycl. Chem. 33 1996 1519 1531
11. D.L. Boger, and S.M. Weinreb H.H. Wasserman Hetero Diels-Alder Methodology in Organic Synthesis Vol. 47 1987 Academic New York
12. D.L. Boger Chem. Rev. 86 1986 781 793
13. (a) We described previously some routes to prepare pyridazino-psoralens with the pyridazine ring attached to the furan nucleus in the tetracyclic compound J.C. González-Gómez, L. Santana, and E. Uriarte Synthesis 2002 43 46
14. J.C. González-Gómez, L. Santana, and E. Uriarte Tetrahedron 59 2003 8171 8176
15. J.C. González-Gómez, and E. Uriarte Synlett 2003 2225 2227
16. J.C. González-Gómez, T. Dedola, L. Santana, E. Uriarte, M. Begala, D. Copez, and G. Podda J. Heterocycl. Chem. 37 2000 907 910
17. Firstly reported for benzofuran: G. Seitz, and T. Kämpchen Arch. Pharm. (Weinheim) 309 1976 679 681
18. B. Graffe, M.C. Sacquet, and P. Maitte J. Heterocycl. Chem. 12 1975 247 251
19. J.J. Chambers, D.M. Kurrasch-Orbaugh, M.A. Parker, and D.E. Nichols J. Med. Chem. 44 2001 1003 1010
20. J.J. Chambers, D.M. Kurrasch-Orbaugh, and D.E. Nichols Bioorg. Med. Chem. Lett. 12 2002 1997 1999
21. R.J. Alabaster, H.M. Cottrell, H. Marley, and S.H.B. Wright Synthesis 1988 950 952
22. To see a recent example where a selective oxidation of a dihydrobezofuran ring was accomplished with DDQ in a molecule that also contains a cyclohexene ring J.J. Chambers, J.C. Parrish, N.H. Jensen, D.M. Kurrasch-Orbaugh, D. Marona-Lewicka, and D.E. Nichols J. Med. Chem. 46 2003 3526 3535
23. A five step procedure to benzodifuran 7 from 5-bromo-6-methoxybenzofuran was described in: L.R. Worden, A.W. Burgstahler, K.D. Kaufman, J.A. Weis, and T.K. Schaaf J. Heterocycl. Chem. 6 1969 191 198
24. Personal communication of David E. Nichols, Address: Department of Medicinal Chemistry and Molecular Pharmacology, School of Pharmacy and Pharmacal Sciences, Purdue University.
25. M.F. Braña, M. Cacho, A. Gradillas, B. Pascual-Teresa, and A. Ramos Curr. Pharm. Des. 7 2001 1745 1780
26. X. Bu, J. Chen, L.W. Deady, and W.A. Denny Tetrahedron 58 2002 175 181
27. L.P.G. Wakelin, A. Adams, and W.A. Denny J. Med. Chem. 45 2002 894 901
28. (d) Refs. 4a,b and 6.
29. R.F. Borch, M.D. Bernstein, and H.D. Durst J. Am. Chem. Soc. 93 12 1971 2897 2904
30. A.F. Abdel-Magid, K.G. Carson, B.D. Harris, C.A. Maryanoff, and R.D. Shah J. Org. Chem. 61 1996 3849 3862
31. A related reduction of pyridine derivatives with sodium cyanoborohydride to the corresponding 1,4-dihydropyridines, was previously reported: U. Eisner, and E. Booker J. Chem. Soc. Perkin Trans. 1 1975 929 931
32. D.L. Boger, J.S. Panek, and M. Patel Org. Synth. 70 1991 79 92